On May 25, 2023, Nascent Biotech, Inc. and BioRay Pharmaceutical Co mutually terminated the license agreement entered into on March 31, 2021. Under the terms of the termination agreement the Company now has regained worldwide rights granted under the license agreement at no cost to either Company.